The Memo: Flow Medical Creating the New Standard of Care for Interventional PE Treatment
Under the direction of CEO and Co-Founder Jennifer Fried, Flow Medical is creating the new standard of care for interventional pulmonary embolism (PE) treatment. The company is developing the next generation of thrombolysis catheters to address shortcomings of current devices, such as imprecise lytic dosing and lack of access to small distal vessels.
Under the direction of CEO and Co-Founder Jennifer Fried, Flow Medical is creating the new standard of care for interventional pulmonary embolism (PE) treatment. The company is developing the next generation of thrombolysis catheters to address shortcomings of current devices, such as imprecise lytic dosing and lack of access to small distal vessels.
www.lifesciencemarketresearch.com
The Memo: Flow Medical Creating the New Standard of Care for Interventional PE Treatment -
Life Science Inte...
No comments yet — be the first!